Otamixaban HCl
Product Specifications
CAS Number
409081-12-5
Target
Others, Factor Xa
Related Pathways
Others, Metabolism
Bioactivity
Otamixaban HCl is an experimental injectable anticoagulant direct factor Xa inhibitor, that was investigated for the treatment for acute coronary syndrome. In 2013, Sanofi announced that it had ended development of the drug candidate after poor performance in a Phase III clinical trial.
Smiles
Cl.COC(=O)[C@H](Cc1cccc(c1)C(N)=N)[C@@H](C)NC(=O)c1ccc(cc1)-c1cc[n+]([O-])cc1
Molecular Formula
C25H27ClN4O4
Molecular Weight
482.97
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PROTO76003-20ug 20 µg
Human Glutaredoxin 3/GLRX3 Recombinant Protein
Sign In for Pricing
View Details 
127367-AP 100 µL
Glutamic Pyruvic Transaminase (GPT, Glutamic-pyruvic Transaminase 1, Glutamate Pyruvate Transaminase 1, GPT 1, GPT1, Alanine Aminotransferase 1, AAT1, ALT1, Glutamic-alanine Transaminase 1) (AP) discontinued
Sign In for Pricing
View Details 